ConductScience.org, home

Paper16631238

Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.

Woolderink JM and 5 others. Gynecol Oncol, 2006. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Papers, record 16631238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16631238

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.
PubMed
Journal
Gynecol Oncol
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2006-09-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woolderink JMJorien M
2de Bock GHGeertruida H
3de Hullu JAJoanne A
4Davy MJMargaret J
5van der Zee AGAte G J
6Mourits MJMarian J E

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Neoplasm Recurrence, LocalMajor topic
Vulvar NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Female
Humans
Lymph Node Excision
Lymphatic Metastasis
Middle Aged
Neoplasm Staging
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42503484Risk Factors for Recurrence in Vulvar Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.Cancer Med2026https://conductscience.org/library/papers/42503484PubMed
41716116Depth of Invasion of 13 mm or Greater Accurately Predicted the Risk of Having a Node Positivity in Lymphadenectomy for Squamous Vulvar Cancer.J Obstet Gynaecol Res2026https://conductscience.org/library/papers/41716116PubMed
41530618Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma.Arch Gynecol Obstet2026https://conductscience.org/library/papers/41530618PubMed
39988466Mohs Micrographic Surgery Versus Wide Local Excision in the Treatment of Anogenital Squamous Cell Carcinoma: A Systematic Review.Int J Dermatol2025https://conductscience.org/library/papers/39988466PubMed
37507545Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study.Br J Cancer2023https://conductscience.org/library/papers/37507545PubMed
37369376European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.Int J Gynecol Cancer2023https://conductscience.org/library/papers/37369376PubMed
36199909Necrotizing fasciitis arising from squamous cell carcinoma of the vulva.Dermatol Reports2022https://conductscience.org/library/papers/36199909PubMed
34910394An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva.J Gynecol Oncol2022https://conductscience.org/library/papers/34910394PubMed
34898540Management of Clitoral Melanoma Presenting as an Exophytic Clitoral Mass: A Case Report and Review of the Literature.Curr Oncol2021https://conductscience.org/library/papers/34898540PubMed
34359760Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center.Cancers (Basel)2021https://conductscience.org/library/papers/34359760PubMed
33650029The role of brachytherapy (interventional radiotherapy) for primary and/or recurrent vulvar cancer: a Gemelli Vul.Can multidisciplinary team systematic review.Clin Transl Oncol2021https://conductscience.org/library/papers/33650029PubMed
31823036Cerebral metastasis in recurrent squamous cell carcinoma of the vulva: case report and review of the literature.Arch Gynecol Obstet2020https://conductscience.org/library/papers/31823036PubMed
31355032A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression.Case Rep Oncol Med2019https://conductscience.org/library/papers/31355032PubMed
27765958Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.Geburtshilfe Frauenheilkd2016https://conductscience.org/library/papers/27765958PubMed
26985195Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer.J Contemp Brachytherapy2016https://conductscience.org/library/papers/26985195PubMed
25848321Vulvar cancer: epidemiology, clinical presentation, and management options.Int J Womens Health2015https://conductscience.org/library/papers/25848321PubMed
23263173Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer.Arch Gynecol Obstet2013https://conductscience.org/library/papers/23263173PubMed
17310353[Lymphadenectomy of the inguinal region and pelvis].Chirurg2007https://conductscience.org/library/papers/17310353PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16631238

GET https://conductscience.org/api/papers/v1/16631238/authors